State Contract Pharmacy Lawsuit Weekly Roundup: Updates in West Virginia, Missouri, Kansas

Key briefs were filed this week in state contract pharmacy litigation in West Virginia, Missouri and Kansas.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Major GPO Sues HRSA over Restrictions on How 340B Hospitals Purchase Initial Drug Inventory

Premier, a major GPO, has sued HRSA over a policy restricting how hospitals can purchase initial physical drug inventory.
A major group purchasing organization (GPO) is suing the federal government over a policy that it claims unlawfully restricts how [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Lilly Backs Sanofi Lawsuit Seeking HRSA 340B Records, Argues Contract Pharmacy Agreements Violate 340B Statute

Eli Lilly has filed an amicus brief in support of Sanofi's lawsuit seeking 340B contract pharmacy agreements from HRSA.
Eli Lilly is backing Sanofi’s lawsuit to compel the federal government to release all 340B contract pharmacy agreements, arguing that [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

BI Tightens Contract Pharmacy Restrictions for All Covered Entities

Boehringer Ingelheim recently announced it will tighten its 340B contract pharmacy restrictions by requiring claims data submission.
Drugmaker Boehringer Ingelheim (BI) will begin requiring all 340B covered entities to submit claims data to continue accessing 340B drugs [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Pfizer CEO Calls 340B ‘One of the Biggest Issues’ During Earnings Call Touting $17.1B in Quarterly Revenue

Pfizer CEO Albert Bourla told investors that "340B reform is something that myself and the entire pharma [industry] is setting as a priority."
Pfizer’s top executive told investors this week that the 340B program “is one of the biggest issues,” during an earnings [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Arkansas, Missouri – Oct 24

Key briefs were filed this week in state contract pharmacy litigation in Arkansas and Missouri.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Kalderos to Resume Legal Battle Over HRSA’s Opposition to Drugmaker 340B Restrictions, Including Rebates

Kalderos will soon file an amended complaint in its case against HRSA before the U.S. District Court for the District of Columbia.
Kalderos, the drug industry vendor behind two 340B claims data submission platforms which support 340B rebates, will file an updated [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

UCB Extends Contract Pharmacy Restrictions to All Federal Grantees

UCB announced extended 340B contract pharmacy restrictions that will take effect Nov. 25.
Belgium pharmaceutical giant UCB is extending its 340B contract pharmacy restrictions to all federal grantees and adding new data submission [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Fifth Hospital Sues HRSA for Authorizing ‘Unlawful’ J&J 340B Audits

University of Washington Medical Center sued HRSA for authorizing an allegedly unlawful 340B program audit of the hospital.
A Washington state hospital on Tuesday became the fifth provider to sue the federal government for authorizing Johnson & Johnson [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drugmakers Urge Federal Appeals Court to Dismiss California Health System’s 340B Whistleblower Lawsuit

AbbVie, AstraZeneca, Novartis and Sanofi asked a federal appeals court to dismiss Adventist's 340B whistleblower lawsuit against them.
Four drugmakers are urging a federal appeals court to affirm a lower court’s decision to dismiss a California health system’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live